Skip to Content

Notice

National Cancer Institute: Opportunity for a Clinical Trial Cooperative Research and Development Agreement (Clinical Trial ``CRADA'') for the Scientific and Commercial Development of the Signal Transduction Inhibitor, ``CAI'', as an Anticancer Agent

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

The full text of this document is currently available in PDF format.

The full text of this document is also available in a basic text format.